A rapid and simple high-performance liquid chromatography assay for the leflunomide metabolite, teriflunomide (A77 1726), in renal transplant recipients

American Journal of Clinical Pathology

Volumn 133, Issue 3, 2010, Pages 454-457

  Sobhani, Kimia ^a   Garrett, Danette A ^a   Liu, Dong Pei ^a   Rainey, Petrie M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

A77 1726; Antiviral; BK polyomavirus; Cytomegalovirus; Drug monitoring; High performance liquid chromatography; Immunosuppressant; Kidney transplantation; Leflunomide; Teriflunomide

Indexed keywords

LEFLUNOMIDE; TERIFLUNOMIDE; CROTONIC ACID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; ISOXAZOLE DERIVATIVE; TOLUIDINE DERIVATIVE;

ARTICLE; BK VIRUS; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; VIRUS INFECTION; DRUG MONITORING; MASS SPECTROMETRY; METHODOLOGY; POLYOMAVIRUS INFECTION; REGRESSION ANALYSIS;

BK VIRUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROTONIC ACIDS; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; POLYOMAVIRUS INFECTIONS; REGRESSION ANALYSIS; TOLUIDINES;

EID: 77949411925     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPR23YAOYFSZTX     Document Type: Article

References (17)

1. Mladenovic V, Domljan Z, Rozman B, et al. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis: results of a randomized, placebo-controlled, phase II study. Arthritis Rheum. 1995;38:1595-1603.
2. Fox RI. Mechanism of action of leflunomide in rheumatoid arthritis. J Rheumatol Suppl. 1998;53:20-26. (Pubitemid 28335318)
3. Leflunomide approved for rheumatoid arthritis; other drugs nearing approval. Am J Health Syst Pharm. 1998;55:2225-2226.
4. Xu X, Shen J, Mall JW, et al. In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action. Biochem Pharmacol. 1999;58:1405-1413. (Pubitemid 29438642)
5. Williams JW, Mital D, Chong A, et al. Experiences with leflunomide in solid organ transplantation. Transplantation. 2002;73:358-366. (Pubitemid 34174284)
6. Josephson MA, Williams JW, Chandraker A, et al. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis. 2006;8:95-101. (Pubitemid 43829486)
7. Faguer S, Hirsch HH, Kamar N, et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int. 2007;20:962-969. (Pubitemid 47537566)
8. Chong AS, Zeng H, Knight DA, et al. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant. 2006;6:69-75. (Pubitemid 43382202)
9. Fox RI, Herrmann ML, Frangou CG, et al. Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol. 1999;93:198-208.
10. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy [letter]. N Engl J Med. 2005;352:1157-1158.
11. Waldman WJ, Knight DA, Lurain NS, et al. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999;68:814-825.
12. Waldman WJ, Knight DA, Blinder L, et al. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999;42:412-418.
13. Leca N, Muczynski KA, Jefferson JA, et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol. 2008;3:829-835.
14. van Roon EN, Yska JP, Raemaekers J, et al. A rapid and simple determination of A77 1726 in human serum by high-performance liquid chromatography and its application for optimization of leflunomide therapy. J Pharm Biomed Anal. 2004;36:17-22.
15. Schmidt A, Schwind B, Gillich M, et al. Simultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high-performance liquid chromatography. Biomed Chromatogr. 2003;17:276-281.
16. Dias VC, Lucien J, LeGatt DF, et al. Measurement of the active leflunomide metabolite (A77 1726) by reverse-phase high-performance liquid chromatography. Ther Drug Monit. 1995;17:84-88.
17. Chan V, Charles BG, Tett SE. Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;803:331-335.